We are live on
!
Find out more
PAWC
P.A.W. Capital Portfolio holdings
AUM
$131M
1-Year Est. Return
46.14%
This Fund
S&P 500
This Quarter
Est. Return
-6.88%
1 Year Est. Return
+46.14%
3 Year Est. Return
+67.18%
5 Year Est. Return
+64.85%
10 Year Est. Return
+1,459.33%
AUM
$112M
AUM Growth
-$6.73M
(-5.6%)
Cap. Flow
+$6.19M
Cap. Flow
% of AUM
5.51%
Top 10 Holdings %
Top 10 Hldgs %
44.74%
Holding
69
New
5
Increased
14
Reduced
16
Closed
6
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PENG
Penguin Solutions Inc
PENG
|
+$3.83M |
| 2 |
Enovix
ENVX
|
+$3.68M |
| 3 |
EverQuote
EVER
|
+$2.03M |
| 4 |
indie Semiconductor
INDI
|
+$1.95M |
| 5 |
RCM
R1 RCM Inc. Common Stock
RCM
|
+$1.65M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
EMKR
Emcore Corp
EMKR
|
+$2.44M |
| 2 |
OptimizeRx
OPRX
|
+$2.17M |
| 3 |
Ambarella
AMBA
|
+$1.49M |
| 4 |
OTRK
Ontrak
OTRK
|
+$974K |
| 5 |
TFFP
TFF Pharmaceuticals, Inc. Common Stock
TFFP
|
+$721K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.03% |
| 2 | Communication Services | 18.15% |
| 3 | Healthcare | 17.13% |
| 4 | Industrials | 10.95% |
| 5 | Consumer Staples | 6.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
GSK
GSK
$104B
| $764K | 0.68% |
16,000
| – | – |
|
52
Lockheed Martin
LMT
$134B
| $759K | 0.68% |
2,200
+200
| +10% | +$72.4K |
|
53
AbbVie
ABBV
$443B
| $755K | 0.67% |
7,000
| – | – |
|
54
Dow Inc
DOW
$21.9B
| $748K | 0.67% |
13,000
| – | – |
|
55
Kraft Heinz
KHC
$30.7B
| $736K | 0.65% |
20,000
| – | – |
|
56
Bristol-Myers Squibb
BMY
$133B
| $710K | 0.63% |
+12,000
| New | +$790K |
|
57
Abbott
ABT
$183B
| $709K | 0.63% |
6,000
| – | – |
|
58
3M
MMM
$90.9B
| $702K | 0.62% |
4,784
| – | – |
|
59
AT&T
T
$159B
| $675K | 0.6% |
33,100
| – | – |
|
|
POL.WS
60
DELISTED
Polished.com Inc. Warrants to Purchase Common Stock
POL.WS
| $672K | 0.6% |
400,000
-300,000
| -43% | -$476K |
|
61
Galmed Pharmaceuticals
GLMD
$5.13M
| $558K | 0.5% |
1,111
| – | – |
|
62
H&R Block
HRB
$5.58B
| $375K | 0.33% |
15,000
-15,000
| -50% | -$374K |
|
63
Blackstone
BX
$102B
| – | – |
-6,000
| Closed | -$583K |
|
|
EVRI
64
CALL
DELISTED
Everi Holdings
EVRI
| – | – |
-80,000
| Closed | -$2M |
|
|
65
OptimizeRx
OPRX
$114M
| – | – |
-35,000
| Closed | -$2.17M |
|
|
OTRK
66
DELISTED
Ontrak
OTRK
| – | – |
-333
| Closed | -$974K |
|
|
TFFP
67
DELISTED
TFF Pharmaceuticals, Inc. Common Stock
TFFP
| – | – |
-3,000
| Closed | -$721K |
|
|
EMKR
68
DELISTED
Emcore Corp
EMKR
| – | – |
-26,500
| Closed | -$2.44M |
|
Similar funds
EIM
CIP
AC
ADEF
LC
EWP
OIM
EPI
P.A.W. Capital's Q3 2021 Portfolio in Review
As of Q3 2021, P.A.W. Capital held 69 positions worth $112M, down 5.6% from $119M the previous quarter. Its ten largest holdings account for 45% of the portfolio.
P.A.W. Capital deployed $6.19M of net new capital in Q3 2021, opening 5 new positions and adding to 14 existing holdings. Its largest new stake was Penguin Solutions Inc: 160,000 shares worth $3.56M.
By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 30% a quarter earlier, followed by Communication Services and Healthcare.
On the sell side, the largest reduction was Ambarella, an estimated $1.49M trimmed.
- P.A.W. Capital's largest Q3 2021 buy was Penguin Solutions Inc: 160,000 shares worth $3.56M.
- P.A.W. Capital added most to EverQuote in Q3 2021, an estimated $2.03M increase.
- P.A.W. Capital's biggest Q3 2021 reduction was Ambarella, cutting an estimated $1.49M.
- P.A.W. Capital fully exited Emcore Corp in Q3 2021, selling an estimated $2.44M.
- P.A.W. Capital's ten largest holdings make up 45% of its $112M portfolio in Q3 2021.
- P.A.W. Capital opened 5 new positions and closed 6 in Q3 2021.
- P.A.W. Capital's portfolio value fell 5.6% quarter-over-quarter to $112M.
Based on P.A.W. Capital's 13F filing for Q3 2021, filed 25 Oct 2021.